The Weekly Roundup: May 12-17

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Motherhood and Dermatoses: Exploring the Connection Between Pregnancy, Breastfeeding, and the Skin

This Mother's Day, we are reviewing the interconnected relationships between pregnancy, breastfeeding, skin conditions, and managing dermatoses.

QUIZ: Advanced Skin Cancer Awareness

Click here to read more and answer our quiz questions in recognition of Skin Cancer Awareness Month.

Revealing Ruxolitinib’s Potential in Pediatric AD Treatment

5 experts share insights on long-term safety, efficacy, demographic variances, and more in pediatric AD.

Expert Panel Confirms Efficacy and Safety of Roflumilast Topical Foam for Seborrheic Dermatitis Across Diverse Hair Types

They are confident prescribing roflumilast to patients with diverse skin and hair characteristics, including those with a history of hair treatments.

Skin Cancer Roundup: The Year so Far

This Skin Cancer Awareness Month, take a look at previous coverage from 2024.

Journal Digest: May 13

This week’s collection of the latest dermatologic studies includes artificial intelligence in cutaneous lesions, dupilumab-induced acanthosis nigricans, aesthetic considerations for treating lesbian, gay, and bisexual patients, and monotherapies for male androgenetic alopecia.

Sonidegib Plus Calcium Supplementation for Improved Management of BCC and HHI-Related Muscle Spasms

Muscle spasms are the most common adverse event experienced by patients treated with hedgehog inhibitors for basal cell carcinomas.

ICYMI: sBLA for Hyrimoz (Adalimumab-adaz) Approved as Interchangeable Biosimilar to Humira

Last week, the FDA approved an sBLA for Sandoz’s adalimumab-adaz in various strengths, including 10 mg/0.1 mL, 20 mg/0.2 mL, and 80 mg/0.8 mL.

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 2

A 5-expert panel continues their conversation on atopic dermatitis, exploring beyond steroids and addressing unmet needs.

Merck Halts Dosing of Anti-TIGIT Antibody in KeyVibe-010 Melanoma Study

The analysis revealed a higher rate of discontinuations due to immune-mediated adverse experiences.

Reviewing a Year of Plaque Psoriasis Progress: Therapies, Data, and Education

Mark Lebwohl, MD, and Saakshi Khattri, MD, discuss the evolving landscape of plaque psoriasis treatments over the past year.

Pediatric Dermatologists Outperform Artificial Intelligence; ChatGPT Demonstrates Comparability in Some Aspects

In a comparison of pediatric dermatologists versus AI, dermatologists primarily exhibited greater performance.

Abrocitinib Demonstrates High Efficacy In Itch-Dominant Atopic Dermatitis

Researchers found that abrocitinib demonstrated rapid, sustained, and deep improvements in several important domains of itch-dominant AD.

Hyper- and Hypopigmentation and Burning Among Most Patient-Reported Adverse Effects During Breast Cancer Treatment

The needs assessment surveyed patients’ stage of treatment, radiation-induced dermatologic adverse effects, and over-the-counter products and home remedies that were used.

Why Dermatology PAs and NPs Are More Needed Than Ever After Walmart’s Health Care Fail

Dermatology PAs and NPs continue to address the demand-supply mismatch in dermatologic care and can significantly bring their skills within the primary care model.

Asian American and Pacific Islander Patients Face Increased Odds of Melanoma Treatment Delay

Researchers say addressing socioeconomic differences may be the key to addressing this disparity.

Dermal Filler Videos With Low Quality Health Information Garner High Viewership on Social Media

These results are indicative of the need for dermatologists to discuss social media misinformation and low quality information with their patients.

Hidradenitis Suppurativa Diagnosis May Be Predicted and Supported By Machine Learning Model

Researchers have developed a clinical decision support model using machine learning to assist health care providers in predicting diagnoses of hidradenitis suppurativa.

Don’t Bat an Eye at These Eyelash Insights for Dermatology Clinicians

In this month’s Cosmetic Conundrums column, explore what dermatology clinicians need to know about false eyelashes to help prevent infections or contact dermatitis.

Research Highlights the Importance of Screening Patients for Alcohol Use Disorder

Clinicians, especially those who see patients with inflammatory and pigmentary disorders, should incorporate alcohol use disorder screening measures into all patient visits.

Soligenix Announces Publication of Promising Comparative Data for HyBryte Synthetic Hypericin for CTCL

The results are both confirmatory and extend the response results from a prior phase 3 trial known as FLASH.

Lindus Health and Acinonyx Bio to Partner in Clinical Trial Evaluating a Benzoyl Peroxide Alternative

Acinonyx Bio's topical cream, ACX, targets Propionibacterium acnes.

Deucravacitinib Demonstrates Sustained Efficacy and Safety in 4-Year Psoriasis Trial

Bristol Myers Squibb announced 70% of patients maintained significant improvement after 4 years with no new safety concerns.

MoonLake’s Sonelokimab Trial for HS Advances to Phase 3

VELA is the first phase 3 hidradenitis suppurativa trial to evaluate HiSCR75 as the primary end point.

Exploring the Relationship Between Oligodontia and Hair Abnormalities: A Study Overview

A recent study spotlights an opportunity for interdisciplinary collaboration between dermatologists and orthodontists.

Medical-Toxicological Knowledge Gaps Pose Challenges Despite Advances in Tattooing

Researchers reviewed research into the medical and toxicological viewpoints of tattooing the skin from the past decade.

QUIZ RECAP: Advanced Skin Cancer Awareness

Earlier this week, we shared our second Skin Cancer Awareness Month quiz. Review the answers and your responses below.

Dermatophytoma: A Diagnosis That You Do Not Want to Miss

It is important dermatologists learn to recognize the clinical findings of dermatophytomas and distinguish them from other onychomycosis subtypes because the recommended treatments differ.

Photographer Behind AbbVie's Clearly Me Campaign for Amplifying Voices of Psoriasis Speaks to Advocacy, Awareness

Clearly Me uses portraiture to spotlight the journeys of psoriasis patients Katie Lowes, DaQuane Cherry, Ayesha Patrick, and Joanna “JoJo” Pomerantz.

Baldo Scassellati Sforzolini, MD, PhD, MBA: Expanding Nemolizumab’s Access

Scassellati Sforzolini discusses the significance of Galderma’s nemolizumab receiving 4 additional filing acceptances for prurigo nodularis and atopic dermatitis.